Patents 6071727 - 6071981

 

 

Patent 6071727: Production of microbial cellulose
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds : N-glycoside)

Patent 6071728: Process for the production of crystalline aspartic acid
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing alpha or beta amino acid or substituted amino acid or salts thereof : Aspartic acid (asparaginic acid); asparagine : Xanthan; i.e., xanthomonas-type heteropolysaccharides)

Patent 6071729: Disruption of the cytochrome C gene in xylose-fermenting yeast
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing oxygen-containing organic compound : Containing hydroxy group : Acyclic : Ethanol : Produced as by-product, or from waste, or from cellulosic material substrate : Acellular preparation of polynucleotide)

Patent 6071730: Cell ablation using trans-splicing ribozymes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell : Introducing an oncogene to establish a cell line)

Patent 6071731: Histidyl tRNA synthetase from streptococcus pneumoniae
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Enzyme or microbial cell is immobilized on or in an organic carrier)

Patent 6071732: Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Transferase other than ribonuclease (2.) : Acting on hydrogen peroxide as acceptor (1.11))

Patent 6071733: Method of making recombinant enzyme
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Transferase other than ribonuclease (2.) : Acting on hydrogen peroxide as acceptor (1.11))

Patent 6071734: HBV polymerase, RNase H enzyme derived from HBV polymerase, processes for preparation and uses for screening antiviral agents thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Hydrolase (3. ) : Acting on ester bond (3.1) : Ribonuclease (3.1.4) : Triglyceride splitting (e.g., lipase, etc. (3.1.1.3)))

Patent 6071735: Enzyme preparation with endoglucanase activity
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Hydrolase (3. ) : Acting on glycosyl compound (3.2) : Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4)) : Glucoamylase (3.2.1.3))

Patent 6071736: Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING : Isomerase (5. ))

Patent 6071737: Equine Neospora isolate and its uses
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Protozoa, media therefor : Chlamydomonas)

Patent 6071738: Conversion of organosulfur compounds to oxyorganosulfur compounds for desulfurization of fossil fuels
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Petroleum oil or shale oil treating : Desulfurizing : Cellulose (e.g., plant fibers, etc.))

Patent 6071739: Sample analyzer
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Including measuring or testing : Including a coated reagent or sample layer : Including multiple, stacked layers)

Patent 6071740: Vessel composting process and apparatus
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Bioreactor : Composting apparatus : Including agitation means : Compostor is rotatably mounted : Binds a T-lymphocytic cell or component or product thereof (e.g., T-cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell surface antigen, etc.))

Patent 6071741: Doc tumor suppressor protein and gene
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 6071742: Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 6071743: Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)

Patent 6071744: Compositions and methods for detecting viral infection
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)

Patent 6071745: Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Method of storing cells in a viable state : Human)

Patent 6071746: Regeneration of somatic embryos from plant tissues
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE : Culture, maintenance, or preservation techniques, per se : Involving potato cell or tissue : Contains a polypeptide hormone)

Patent 6071747: Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : Introducing an oncogene to establish a cell line : Helper virus is present)

Patent 6071748: Light detection device
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INCLUDING SAMPLE PREPARATION : With fluorescence or luminescence)

Patent 6071749: Process for forming a semiconductor device with controlled relative thicknesses of the active region and gate electrode
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INCLUDING CONTROL RESPONSIVE TO SENSED CONDITION : Electrical characteristic sensed : Utilizing integral test element : Plasma etching)

Patent 6071750: Method of manufacture of a paddle type ink jet printer
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MANUFACTURE OF ELECTRICAL DEVICE CONTROLLED PRINTHEAD : Electrical characteristic sensed)

Patent 6071751: Deuterium sintering with rapid quenching
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Passivating of surface : Multiple wavelength emissive)

Patent 6071752: Method of making a light reflector
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT RESPONSIVE TO NONELECTRICAL SIGNAL : Physical stress responsive : Having cantilever element : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 6071753: Method of producing a solar cell
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT RESPONSIVE TO NONELECTRICAL SIGNAL : Responsive to electromagnetic radiation : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 6071754: Device and method for stacking wire-bonded integrated circuit dice on flip-chip bonded integrated circuit dice
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Direct application of electrical current)

Patent 6071755: Method of manufacturing semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Direct application of electrical current)

Patent 6071756: Method for holding components in place during soldering
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Assembly of plural semiconductive substrates each possessing electrical device : Contact formation (i.e., metallization))

Patent 6071757: Condensed memory matrix
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Making plural separate devices : Stacked array (e.g., rectifier, etc.))

Patent 6071758: Process for manufacturing a chip card micromodule with protection barriers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Making plural separate devices : Using strip lead frame : And encapsulating : Specified shape junction barrier (e.g., V-grooved junction, etc.))

Patent 6071759: Method for manufacturing semiconductor apparatus
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Including adhesive bonding step : Substrate dicing)

Patent 6071760: Solid-state image sensing device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Metallic housing or support : Lead frame : Utilizing a coating to perfect the dicing)

Patent 6071761: Method for encapsulated integrated circuits
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Encapsulating : And encapsulating)

Patent 6071762: Process to manufacture LDD TFT
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Vertical channel)

Patent 6071763: Method of fabricating layered integrated circuit
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Introduction of nondopant into semiconductor layer : Utilizing backside irradiation)

Patent 6071764: Semiconductor device and process for fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 6071765: Method of forming polycrystalline silicon layer on substrate and surface treatment apparatus thereof
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 6071766: Method for fabricating semiconductor thin film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 6071767: High performance/high density BICMOS process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : And additional electrical device : Including bipolar transistor (i.e., BiCMOS) : Multiple doping steps)

Patent 6071768: Method of making an efficient NPN turn-on in a high voltage DENMOS transistor for ESD protection
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including bipolar transistor (i.e., BiMOS) : And contact formation)

Patent 6071769: Method for forming a resistor load of a static random access memory
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)

Patent 6071770: Semiconductor memory device and method for fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Having high dielectric constant insulator (e.g., Ta2O5, etc.) : Plural doping steps)

Patent 6071771: Semiconductor processing method of forming a capacitor and capacitor constructions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Having high dielectric constant insulator (e.g., Ta2O5, etc.) : Plural doping steps)

Patent 6071772: Method of fabricating a semiconductor memory device having a tree-type capacitor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including doping of semiconductive region)

Patent 6071773: Process for fabricating a DRAM metal capacitor structure for use in an integrated circuit
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including doping of semiconductive region)

Patent 6071774: Method for forming a capacitor with a multiple pillar structure
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including texturizing storage node layer : Multiple doping steps)

Patent 6071775: Methods for forming peripheral circuits including high voltage transistors with LDD structures
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)

Patent 6071776: Flash memory structure and method of manufacture
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)

Patent 6071777: Method for a self-aligned select gate for a split-gate flash memory structure
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)

Patent 6071778: Memory device with a memory cell array in triple well, and related manufacturing process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)

Patent 6071779: Source line fabrication process for flash memory
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Including elongated source or drain region disposed under thick oxide regions (e.g., buried or diffused bitline, etc.) : Stacked capacitor)

Patent 6071780: Compound semiconductor apparatus and method for manufacturing the apparatus
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Gate insulator structure constructed of diverse dielectrics (e.g., MNOS, etc.) or of nonsilicon compound : Introducing a dopant into the channel region of selected transistors)

Patent 6071781: Method of fabricating lateral MOS transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Doping of semiconductive channel region beneath gate insulator (e.g., adjusting threshold voltage, etc.) : Using channel conductivity dopant of opposite type as that of source and drain : After formation of source or drain regions and gate electrode (e.g., late programming, encoding, etc.))

Patent 6071782: Partial silicidation method to form shallow source/drain junctions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Doping region beneath recessed oxide (e.g., to form chanstop, etc.))

Patent 6071783: Pseudo silicon on insulator MOSFET device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Doping region beneath recessed oxide (e.g., to form chanstop, etc.))

Patent 6071784: Annealing of silicon oxynitride and silicon nitride films to eliminate high temperature charge loss
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Contacts formed by selective growth or deposition)

Patent 6071785: Low resistance ground wiring in a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Contacts formed by selective growth or deposition)

Patent 6071786: Method of manufacturing a bipolar transistor and its emitter contact
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Self-aligned : Recessed oxide by localized oxidation (i.e., LOCOS))

Patent 6071787: Method of forming a capacitor including forming a first and second conductive layers and etching layers to form alloyed conductive
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Self-aligned : Dopant implantation or diffusion : Simultaneously outdiffusing plural dopants from polysilicon or amorphous semiconductor)

Patent 6071788: Method of manufacturing a semiconductor device with a conductor film having a polycrystalline structure
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Radiation or energy treatment modifying properties of semiconductor regions of substrate (e.g., thermal, corpuscular, electromagnetic, etc.))

Patent 6071789: Method for simultaneously fabricating a DRAM capacitor and metal interconnections
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Stacked capacitor : Including doping of semiconductive region)

Patent 6071790: Method of crown capacitor rounding by oxidant dipping process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Stacked capacitor : Including texturizing storage node layer : Multiple doping steps)

Patent 6071791: Radiation-hardening of microelectronic devices by ion implantation into the oxide and annealing
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Implanting to form insulator : Enclosed cavity)

Patent 6071792: Methods of forming shallow trench isolation regions using plasma deposition techniques
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Enclosed cavity)

Patent 6071793: Locos mask for suppression of narrow space field oxide thinning and oxide punch through effect
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Enclosed cavity)

Patent 6071794: Method to prevent the formation of a thinner portion of insulating layer at the junction between the side walls and the bottom insulator
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Enclosed cavity)

Patent 6071795: Separation of thin films from transparent substrates by selective optical processing
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : BONDING OF PLURAL SEMICONDUCTOR SUBSTRATES : Subsequent separation into plural bodies (e.g., delaminating, dicing, etc.) : And electrical conductor formation (i.e., metallization))

Patent 6071796: Method of controlling oxygen incorporation during crystallization of silicon film by excimer laser anneal in air ambient
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Amorphous semiconductor : And subsequent crystallization : Utilizing wave energy (e.g., laser, electron beam, etc.) : Dopant addition)

Patent 6071797: Method for forming amorphous carbon thin film by plasma chemical vapor deposition
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Polycrystalline semiconductor : And subsequent crystallization)

Patent 6071798: Method for fabricating buried contacts
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INTRODUCTION OF CONDUCTIVITY MODIFYING DOPANT INTO SEMICONDUCTIVE MATERIAL : Ion implantation of dopant into semiconductor region : Forming buried region : And contact formation (i.e., metallization))

Patent 6071799: Method of forming a contact of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : Insulated gate formation : Having sidewall structure : Separated by insulator (i.e., floating gate))

Patent 6071800: Electronic device and manufacturing method thereof
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Forming solder contact or bonding pad : Transparent conductor)

Patent 6071801: Method and apparatus for the attachment of particles to a substrate
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Forming solder contact or bonding pad : Transparent conductor)

Patent 6071802: Method for manufacturing semiconductor device having self-aligned contact
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Bump electrode)

Patent 6071803: Electrical contact to buried SOI structures
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Bump electrode)

Patent 6071804: Method of fabricating bit lines by damascene
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Bump electrode)

Patent 6071805: Air gap formation for high speed IC processing
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Air bridge structure : Including fusion of conductor)

Patent 6071806: Method for preventing poisoned vias and trenches
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Including fusion of conductor)

Patent 6071807: Fabrication method of semiconductor device including insulation film with decomposed organic content
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Including organic insulating material between metal levels : By wire bonding)

Patent 6071808: Method of passivating copper interconnects in a semiconductor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Having planarization step : Simultaneously by chemical and mechanical means : Silicide formation)

Patent 6071809: Methods for forming high-performing dual-damascene interconnect structures
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Having planarization step : Utilizing etch-stop layer : Silicide formation)

Patent 6071810: Method of filling contact holes and wiring grooves of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Insulator formed by reaction with conductor (e.g., oxidation, etc.) : Utilizing etch-stop layer)

Patent 6071811: Deposition of titanium nitride films having improved uniformity
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Diverse conductors : Having refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof) : Utilizing reflow)

Patent 6071812: Method of forming a modified metal contact opening to decrease its aspect ratio for deep sub-micron processes
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Specified configuration of electrode or contact : Specified aspect ratio of conductor or viahole : Forming silicide)

Patent 6071813: Method and system for electrical coupling to copper interconnects
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Copper of copper alloy conductor : Of refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof))

Patent 6071814: Selective electroplating of copper for damascene process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Copper of copper alloy conductor : Of refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof))

Patent 6071815: Method of patterning sidewalls of a trench in integrated circuit manufacturing
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : To form ohmic contact to semiconductive material)

Patent 6071816: Method of chemical mechanical planarization using a water rinse to prevent particle contamination
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with the removal of material by nonchemical means (e.g., ablating, abrading, etc.) : Combined mechanical and chemical material removal : Simultaneous (e.g., chemical-mechanical polishing, etc.) : Forming silicide)

Patent 6071817: Isolation method utilizing a high pressure oxidation
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with the removal of material by nonchemical means (e.g., ablating, abrading, etc.) : Combined mechanical and chemical material removal : Simultaneous (e.g., chemical-mechanical polishing, etc.) : Forming silicide)

Patent 6071818: Endpoint detection method and apparatus which utilize an endpoint polishing layer of catalyst material
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with the removal of material by nonchemical means (e.g., ablating, abrading, etc.) : Combined mechanical and chemical material removal : Simultaneous (e.g., chemical-mechanical polishing, etc.) : Forming silicide)

Patent 6071819: Flexible skin incorporating mems technology
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with coating step : Combined mechanical and chemical material removal)

Patent 6071820: Method for patterning integrated circuit conductors
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Plural coating steps)

Patent 6071821: Dry etching method of thin film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Plural coating steps)

Patent 6071822: Etching process for producing substantially undercut free silicon on insulator structures
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Reactive ion beam etching (i.e., RIBE) : Silicide)

Patent 6071823: Deep trench bottle-shaped etch in centura mark II NG
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Including change in etch influencing parameter (e.g., energizing power, etchant composition, temperature, etc.) : Silicide)

Patent 6071824: Method and system for patterning to enhance performance of a metal layer of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Utilizing multilayered mask : Silicide)

Patent 6071825: Fully overlapped nitride-etch defined device and processing sequence
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Silicon : Silicide)

Patent 6071826: Method of manufacturing CMOS image sensor leakage free with double layer spacer
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Silicon oxide or glass : Silicide)

Patent 6071827: Method for manufacturing semiconductor devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Organic material (e.g., resist, etc.) : Silicide)

Patent 6071828: Semiconductor device manufacturing method including plasma etching step
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Differential etching of semiconductor substrate : Substrate possessing multiple layers : Electrically conductive material (e.g., metal, conductive oxide, etc.) : Utilizing etch stop layer)

Patent 6071829: Method of fabricating semiconductor components
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Liquid phase etching : Utilizing electromagnetic or wave energy : Substrate possessing multiple layers)

Patent 6071830: Method of forming insulating film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Insulative material deposited upon semiconductive substrate : Reaction with silicon semiconductive region (e.g., oxynitride formation, etc.))

Patent 6071831: Method of reducing spiral defects by adding an isopropyl alcohol rinse step before depositing sog
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Insulative material deposited upon semiconductive substrate : Reaction with silicon semiconductive region (e.g., oxynitride formation, etc.))

Patent 6071832: Method for manufacturing a reliable semiconductor device using ECR-CVD and implanting hydrogen ions into an active region
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Insulative material deposited upon semiconductive substrate : Silicon oxide formation : Introduction simultaneous with deposition)

Patent 6071833: Method of repairing walls and ceilings
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : SCRIM (E.G., OPEN NET OR MESH, GAUZE, LOOSE OR OPEN WEAVE OR KNIT, ETC.) : Woven scrim : Including a layer derived from a water-settable material (e.g., cement, gypsum, etc.) : Polyolefin film or sheet)

Patent 6071834: Dimensionally stabilized breathable membrane
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : SCRIM (E.G., OPEN NET OR MESH, GAUZE, LOOSE OR OPEN WEAVE OR KNIT, ETC.) : Nonwoven scrim : Comprising a composite fiber : Bitumen coating or impregnation)

Patent 6071835: Load limiting webbing
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : WOVEN FABRIC (I.E., WOVEN STRAND OR STRIP MATERIAL) : Woven fabric is characterized by a particular or differential weave other than fabric in which the strand denier or warp/weft pick count is specified : Warp differs from weft : Materials differ : Including synthetic polymeric strand material : Including polyester strand material :)

Patent 6071836: Polybutadiene and polyisoprene thermosetting compositions and method of manufacture thereof
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : WOVEN FABRIC (I.E., WOVEN STRAND OR STRIP MATERIAL) : Including a free metal or alloy constituent : Preformed metallic film or foil or sheet (film or foil or sheet had structural integrity prior to association with the woven fabric) : Including particulate material other than fiber : Including a nonwoven fabric layer)

Patent 6071837: Tissue membrane felt
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : WOVEN FABRIC (I.E., WOVEN STRAND OR STRIP MATERIAL) : Woven fabric including a nonwoven fabric layer other than paper : Three or more distinct layers)

Patent 6071838: Silica gel, synthetic quartz glass powder, quartz glass shaped product molding, and processes for producing these
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Glass compositions, compositions containing glass other than those wherein glass is a bonding agent, or glass batch forming compositions : Made by gel route : Divalent metal oxide aluminosilicate crystalline phase (e.g., anorthite, slagcerams, etc.))

Patent 6071839: Colorant glasses
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Glass compositions, compositions containing glass other than those wherein glass is a bonding agent, or glass batch forming compositions : Silica containing : 40 percent - 90 percent by weight silica : And aluminum or iron compound : And divalent metal oxide (e.g., oxides of zinc, cadmium, beryllium, alkaline earth metal, magnesium, etc.) : And zinc or zirconium)

Patent 6071840: Dark green colored glass
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Glass compositions, compositions containing glass other than those wherein glass is a bonding agent, or glass batch forming compositions : Silica containing : 40 percent - 90 percent by weight silica : And aluminum or iron compound : And divalent metal oxide (e.g., oxides of zinc, cadmium, beryllium, alkaline earth metal, magnesium, etc.) : Calcium oxide containing : And chromium, nickel, or cobalt :)

Patent 6071841: Cubic boron nitride sintered body and method of preparing the same
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Refractory : Boride, silicide, nitride, oxynitride, carbonitride, or oxycarbonitride containing : Boron nitride containing : Whisker containing)

Patent 6071842: Barium titanate-based semiconductor ceramic
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Titanate, zirconate, stannate, niobate, or tantalate or oxide of titanium, zirconium, tin, niobium, or tantalum containing (e.g., dielectrics, etc.) : Alkaline earth or magnesium containing : Titanate containing : Barium titanate : And clay containing)

Patent 6071843: Process for reactivating catalyst systems containing a platinum group metal
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : REGENERATING OR REHABILITATING CATALYST OR SORBENT : Treating with a liquid or treating in a liquid phase, including dissolved or suspended : Using acid : Ammonia or derivative thereof)

Patent 6071844: Method of producing .epsilon.-Caprolactam, MFI zeolite catalysts on whose surface symmetrically arranged OH groups are present and to a
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : ZEOLITE OR CLAY, INCLUDING GALLIUM ANALOGS : ZSM type : Mixed clays)

Patent 6071845: Catalyst for producing conjugated diene polymer
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Sulfuric or hydrochloric acid)

Patent 6071846: Olefin polymerization catalyst and a polyolefin production method
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : And a third component C (i.e., an additive other than a saturated hydrocarbon or an aromatic hydrocarbon free of aliphatic or cycloaliphatic unsaturation) : Nonmetallic organic oxygen containing : Including element in addition to carbon, hydrogen, and nitrogen (e.g, nitro, etc.))

Patent 6071847: Gas phase anionic polymerization of diene elastomers
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : Organic compound including carbon-metal bond : And a third component C (i.e., an additive other than a saturated hydrocarbon or an aromatic hydrocarbon free of aliphatic or cycloaliphatic unsaturation))

Patent 6071848: Process for the hydroxylation of aromatic hydrocarbons
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : Organic phosphorus or nitrogen, except the ammonium ion : Alkali metal bonded to carbon)

Patent 6071849: Catalyst for oxidative condensation of lower aliphatic hydrocarbon and method of condensing lower aliphatic hydrocarbon using same
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : Cerium)

Patent 6071850: Multi-layer non-identical catalyst on metal substrate by electrophoretic deposition
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : MISCELLANEOUS (E.G., CARRIER OR SUPPORT PER SE OR PROCESS OF MAKING, ETC.) : Free carbon containing)

Patent 6071851: Heat-sensitive recording material and method for producing same
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING A COLORLESS COLOR-FORMER, DEVELOPER THEREFOR, OR METHOD OF USE :)

Patent 6071852: Pressure-sensitive record materials
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING A COLORLESS COLOR-FORMER, DEVELOPER THEREFOR, OR METHOD OF USE : Identified solvent or dispersant for color-former, other than mere mineral oil : Metal of atomic number 22-30)

Patent 6071853: Crystalline fluoran compound
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING A COLORLESS COLOR-FORMER, DEVELOPER THEREFOR, OR METHOD OF USE : Identified color-former : Furanone moiety-containing : Fluoran or derivative :)

Patent 6071854: Thermally sensitized sheet
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)

Patent 6071855: Glow-in-the-dark medium and method of making
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)

Patent 6071856: Herbicidal compositions for acetochlor in rice
(PLANT PROTECTING AND REGULATING COMPOSITIONS : ANTIDOTES (E.G., SAFENERS, ANTAGONISTS, ETC.) : Antidote contains -C(=X)X-, wherein the X`s are the same or diverse chalcogens (e.g., carbamates, thiocarbamates, carboxylic acids, etc.) : Oxygen containing hetero ring)

Patent 6071857: Pesticidal compositions
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Designated nonactive ingredient containing : Liquid carrier containing (e.g., water, hydrocarbon, etc.) : Gel (i.e., a colloidal solution of a liquid in a solid : Organic nitrogen containing solvent, emulsifier, or foaming agent of formula R1N(R2)2)

Patent 6071858: Stable, dry compositions for use as herbicides
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Hetero ring containing active ingredient : Hetero ring is six-membered including nitrogen : The hetero ring consists of three nitrogens and three carbons : With additional hetero ring active ingredient :)

Patent 6071859: Red tide eliminating composition and method for getting rid of red tide
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Aquatic plant regulator (e.g., algicides, etc.) : Inorganic active ingredient containing : Carboxamides (i.e., R-C(=O)NH2, wherein R is hydrogen or carbon, and substitution may be made for the hydrogens on the nitrogen only; e.g., dichloroacetamides, etc.))

Patent 6071860: 2,4-Diamino-1, 3,5-triazines, their preparation, and their use as herbicides and plant growth regulators
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is six-membered consisting of three nitrogens and three carbons : Nitrogen bonded directly to ring carbon of the six-membered hetero ring : Plural nitrogens bonded directly to ring carbons of the six-membered hetero ring : Additional hetero ring containing)

Patent 6071861: Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Sulfur containing hetero ring : Having -C(=X)-, wherein X is chalcogen, bonded directly to the five-membered hetero ring)

Patent 6071862: Lubricating oil additives
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Compound of indeterminate structure, prepared by reacting an organic -C(=O)O- compound of known structure : Nitrogen attached directly or indirectly to the cyano group by nonionic bonding)

Patent 6071863: Biodegradable polyalphaolefin fluids and formulations containing the fluids
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Solid hydrocarbon polymer : Halogenated acyclic compound or halogenated petroleum fraction)

Patent 6071864: Methods for preparation of arylated poly.varies.olefins
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Solid hydrocarbon polymer : Halogenated acyclic compound or halogenated petroleum fraction)

Patent 6071865: Nail polish remover
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : Nail polish remover : Gas generating (e.g., effervescent, etc.))

Patent 6071866: Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For human skin : Soap component)

Patent 6071867: Cleaning compositions and methods of using the same
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For removing ink, pencil, or writing fluid markings (e.g., ball pen fluid, printer`s or magnetic ink, etc.) : For typewriter)

Patent 6071868: Photoresist stripping composition
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For printed or integrated electrical circuit, or semiconductor device : For stripping photoresist material : Organic sulfoxy containing component (e.g., sulfate, sulfonate, etc.))

Patent 6071869: Fabric cleaning formulations
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For textile material (e.g., laundry detergent, etc.) : For pile fabric or upholstery (e.g., carpet, rug, etc.) : Gel or liquid composition : Plural inhibitor or stabilizer components)

Patent 6071870: Bleaching compositions which contain a peroxygen bleach, a hydrophobic bleach activator, and a long chain alkyl sarcosinate
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For textile material (e.g., laundry detergent, etc.) : For removing stains (other than merely in the course of laundering or dry-cleaning operation) : Prior to laundering (e.g., spotting stick, pre-spot, etc.) : Plural inhibitor or stabilizer components)

Patent 6071871: Cotton soil release polymers
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : With soil-release, anti-soiling, coating, or nonabrasive polishing component (e.g., with polysiloxane, chalk, etc.) : Soap component)

Patent 6071872: Cable cleaning solution comprising a brominated hydrocarbon and an ester
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : Liquid composition : Nonaqueous liquid : Halogenated hydrocarbon component : Oxygen containing component)

Patent 6071873: Liquid cleaning compositions containing a methyl ethoxylated ester
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : Liquid composition : Plural immiscible liquid phases (e.g., emulsion, oily and aqueous layers, etc.) : Sulfur containing anionically substituted surfactant)

Patent 6071874: Human pathogenesis-related protein
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)

Patent 6071875: TGF.alpha. for the treatment of ocular hypertension and glaucoma
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)

Patent 6071876: Method of preventing NMDA receptor complex-mediated neuronal damage
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Insulin or derivative :)

Patent 6071877: Polypeptides having a toxic activity against insects of the dipterae family
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 6071878: Non-hemolytic mosquitocidal microorganisms
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 6071879: Method for the treatment of bacterial infection
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 6071880: Use of IGF-I for the treatment of renal insufficiencies, steriod toxicity and related indications
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 6071881: Peptides and remedy for bone diseases containing the same as active ingredient
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 16 to 24 peptide repeating units in known peptide chain : Monocyclic)

Patent 6071882: Means for treating prostate hypertrophy and prostate cancer
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 9 to 11 peptide repeating units in known peptide chain : Monocyclic)

Patent 6071883: Flavone analogues useful as anti-rejection agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Guanidine containing)

Patent 6071884: Pharmaceutical compositions and therapeutic methods
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Guanidine containing)

Patent 6071885: Treatment of FGF-mediated conditions by administration of a cardiac glycoside or aglycone derivative thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Cyclopentanohydrophenanthrene ring system :)

Patent 6071886: .beta.,.beta.-distributed derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring : The hetero ring has 8 or more ring carbons : The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) :)

Patent 6071888: Composition for treating cancer
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Two or more nitrogen atoms bonded directly to the cyclohexyl ring)

Patent 6071889: In vivo genetic modification of growth factor-responsive neural precursor cells
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071890: Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071891: Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071892: Tyrosyl tRNA synthetase polynucleotides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071893: Interleukin-12 as an adjuvant for paramyxoviridae vaccines
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071894: Sensor histidine kinase of Staphylococcus aureus
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)

Patent 6071895: Polar-substituted hydrocarbons
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Nitrogen containing hetero ring : Polycylo ring system having a ring nitrogen in the system : Quinolinyl or isoquinolinyl (including hydrogenated) : 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.))

Patent 6071896: Suppression of thromboxane levels by percutaneous administration of aspirin
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI : Aspirin per se (i.e., 2-(acetyloxy)benozic acid) : The hetero ring is five-membered)

Patent 6071897: Use of vitamin D compounds to prevent transplant rejection
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI : Nitrogen containing (e.g., anilides, etc.))

Patent 6071898: Asiatic acid derivatives having modified A-ring
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : With a vitamin type active ingredient)

Patent 6071899: Azetidinone derivatives for the treatment of atherosclerosis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is four-membered and includes at least one ring nitrogen : Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen : Alkyl, hydroxyalkyl, alkoxyalkyl or alkanoyloxyakyl bonded directly to 3-position)

Patent 6071900: Heterocyclic compounds and their use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Two of the cyclos share at least three ring carbons (i.e., bridged) : Two of the cyclos share at least three ring members (i.e., bridged))

Patent 6071901: Substituted dibenz[b,f]azepines and uses thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-membered hetero ring a one of the cyclos : Two of the cyclos share at least three ring members (i.e., bridged))

Patent 6071902: Method for treating excessive aggression
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the additional hetero ring)

Patent 6071903: 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Bicyclo ring system having the seven-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the additional hetero ring)

Patent 6071904: Process for manufacturing ophthalmic suspensions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Three or more ring hetero atoms in the six-membered hetero ring : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the additional hetero ring)

Patent 6071905: Biologically active substance on the basis of tetracyclic nitrogen heterocycles of pyrimidine row
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.) : At least three cyclos in the polycyclo ring system : 1,2,4 - Benzothiadiazine - 1,1 - dioxides (including hydrogenated))

Patent 6071906: Imidino piperidine derivatives useful as nitric oxide synthase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : 1,3-Thiazines : Chalcogen or nitrogen bonded directly to ring carbon of the six-membered hetero ring : Phenothiazines (including hydrogenated))

Patent 6071907: Tricyclic compounds useful as FPT inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : 1,4-Thiazines : Additional hetero ring attached directly or indirectly to the 1,4-thiazine by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Chalcogen or nitrogen attached indirectly to the phenothiazine ring nitrogen by acyclic nonionic bonding)

Patent 6071908: Radiation-activated cytotoxin therapy of neoplastic disease
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Additional hetero ring attached directly or indirectly to the morpholines by nonionic bonding)

Patent 6071909: Phenylbenzimidazole derivatives as ligands for GABA receptors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Bicyclo ring system having the additional hetero ring as one of the cyclos : Plural ring hetero atoms in the bicyclo ring system : Plural ring nitrogens in the bicyclo ring system : The additional hetero ring contains ring nitrogen)

Patent 6071910: Use of agents to treat eosinophil-associated pathologies
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Ring nitrogen in the additional hetero ring : Bicyclo ring system having the additional hetero ring as one of the cyclos)

Patent 6071911: 4-amino-1-arylpyridin-2-ones and process for making
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Ring nitrogen in the additional hetero ring : Bicyclo ring system having the additional hetero ring as one of the cyclos)

Patent 6071912: Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Morpholines (i.e., fully hydrogenated 1,4- oxazines))

Patent 6071913: Angiotensin II receptor antagonistic 1,2,4-triazin-5-one derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Asymmetrical (e.g., 1,2,4-triazine, etc.) : Carbocyclic ring attached indirectly to the morpholine ring by nonionic bonding)

Patent 6071914: Method for inhibiting neoplastic disease in mammals
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : At least three rings in the polycyclo ring system : The additional hetero ring is attached indirectly to the morpholine ring by an acyclic chain having a hetero atom as a chain member)

Patent 6071915: Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Chalcogen bonded directly to ring carbon of the additional six-membered nitrogen containing hetero ring : The five-membered nitrogen hetero ring has chalcogen as a ring member)

Patent 6071916: HIV protease inhibitor
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : Ring oxygen in the additional hetero ring : Polycyclo ring system having the additional oxygen hetero ring as one of the cyclos : Indole ring system (including hydrogenated) attached directly or indirectly to the piperazine ring by nonionic bonding)

Patent 6071917: N-benzenesulphonyl-L-proline derivatives as bradykinin B.sub.2 antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos : Bicyclo ring having the additional six-membered nitrogen hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Having -C(=X)-, wherein X is chalcogen, bonded directly to the additional hetero ring)

Patent 6071918: Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Plural hetero atoms in the polycyclo ring system : Carbocyclic ring bonded directly to a ring carbon of the quinazoline ring system)

Patent 6071919: Zwitterionic compositions and methods as biological response modifiers
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Polycyclo ring system having the additional five-membered hetero ring as one of the cyclos)

Patent 6071920: 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : Isoalloxazine (e.g., riboflavins, Vitamin B2, etc.))

Patent 6071921: Chemical compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) : Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding : The additional hetero ring is six-membered consisting of one nitrogen and five carbons : Piperidinyl or tetrahydropyridyl : Chalcogen attached indirectly to the 9- position of the purine ring system by acyclic nonionic bonding)

Patent 6071922: Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety : Chalcogen bonded directly to pyrimidine at 2-position : The nitrogen is part of a hetero ring)

Patent 6071923: Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : 1,3-diazines (e.g., pyrimidines, etc.))

Patent 6071924: Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : 1,3-diazines (e.g., pyrimidines, etc.))

Patent 6071925: 1,3,8-triazaspiro[4,5]decan-4-one derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Spiro ring system : Thiamines (e.g., vitamin B1, etc.))

Patent 6071926: Sleep quality improvement using a growth hormone secretagogue
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Spiro ring system : Thiamines (e.g., vitamin B1, etc.))

Patent 6071927: Spiro-piperidine derivatives and their use as therapeutic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Spiro ring system : Thiamines (e.g., vitamin B1, etc.))

Patent 6071928: Spiro-piperidine derivatives and their use as therapeutic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Spiro ring system : Thiamines (e.g., vitamin B1, etc.))

Patent 6071929: Octahydro phenanthridine derivatives useful as NMDA-R receptor subtype blockers
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tetracyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tetracyclo ring system (e.g., acronycines, etc.) : Three or more hetero atoms in the tetracyclo ring system : Nitrogen bonded directly to ring carbon of the 1,3-diazine ring of the quinazoline ring system)

Patent 6071930: Method for treating tumors using 2-aryl-naphthyridin-4-ones
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the bicyclo ring system : Plural ring nitrogens in the tricyclo ring system)

Patent 6071931: AT.sub.1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the bicyclo ring system : Exactly three ring nitrogens in the bicyclo ring system : Three or more hetero atoms in the tricyclo ring system)

Patent 6071932: Carbazolypiperines as GABA uptake inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring nitrogen in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)

Patent 6071933: Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Nitrogen attached directly to the piperidine ring by nonionic bonding : Plural chalcogens bonded directly to ring carbons of the piperidine ring)

Patent 6071934: Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms : Additional ring containing)

Patent 6071935: Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms : Additional hetero ring other than the six-membered hetero rings : Nitrogen attached indirectly to the piperidine ring by nonionic bonding)

Patent 6071936: Substituted pyridines as selective cyclooxygenase-2 inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms : The six-membered hetero rings are bonded directly to each other : Nitrogen attached indirectly to the piperidine ring by nonionic bonding)

Patent 6071937: Oxymethoxy-3-aryl-pyrone derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : Chalcogen bonded directly to a ring carbon of the six-membered hetero ring)

Patent 6071938: Benzopyrans
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : The additional hetero ring is one of the cyclos in a polycyclo ring system : Nitrogen attached indirectly to the piperidine ring by nonionic bonding)

Patent 6071939: Medicaments for the treatment of hypertension
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : C=O bonded directly to the six-membered hetero ring : At 3-position : C=O in a C(=O)O group (e.g., nicotinic acid, etc.) : Plural chalcogens bonded directly to ring carbons of the piperidine ring)

Patent 6071940: Fungicidal active compound combinations
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2,4-triazoles (including hydrogenated) : Additional chalcogen containing hetero ring)

Patent 6071941: Protection of trees
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2,4-triazoles (including hydrogenated) : Additional chalcogen containing hetero ring)

Patent 6071942: Elevation of circulating blood histamine levels
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : Imidazoles : Benzo fused at 4,5-positions of the diazole ring)

Patent 6071943: Imidazole derivative and medicine comprising the same as active ingredient
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : Imidazoles : Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding : At imidazole ring carbon : Ring sulfur in the polycyclo ring system)

Patent 6071944: Method of treatment of pigmented cancer cells utilizing photodynamic therapy
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Pyrazoles)

Patent 6071945: 8H-thieno-[2,3-b]pyrrolizin-8-one compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Tricyclo ring system having the five-membered hetero ring as one of the cyclos : At imidazole ring carbon)

Patent 6071946: Tricyclic urea compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Tricyclo ring system having the five-membered hetero ring as one of the cyclos : At imidazole ring carbon)

Patent 6071947: Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Bicyclo ring system having the five-membered hetero ring as one of the cyclos : Additional hetero ring which is not part of the bicyclo ring system : Ring sulfur in the polycyclo ring system)

Patent 6071948: Methods and compositions for inhibition of angiogenesis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Bicyclo ring system having the five-membered hetero ring as one of the cyclos : The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.) : The ring nitrogen is bonded directly to nonshared ring carbons of the five-membered hetero ring (e.g., isoindole, etc.) : Plural ring nitrogens in the polycyclo ring system)

Patent 6071949: Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Bicyclo ring system having the five-membered hetero ring as one of the cyclos : The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.) : Chalcogen bonded directly to ring carbon of the five-membered hetero ring : Plural chalcogens bonded directly to ring carbons of the five-membered hetero ring (e.g., phthalimide, etc.))

Patent 6071950: N-substituted pyrrolidine derivatives and process for preparing the same
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding : Bicyclo ring system having the five-membered hetero ring as one of the cyclos)

Patent 6071951: Arylpyrroles for subterranean termite control
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.) : Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding)

Patent 6071952: Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered)

Patent 6071953: Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is six-membered : Polycyclo ring system having the hetero ring as one of the cyclos : Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.) : Coumarins (including hydrogenated) : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen))

Patent 6071954: (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered : Chalcogen bonded directly to the hetero ring : The nitrogen bonded directly to the hetero ring)

Patent 6071955: FXR, PPARA and LXRA activators to treat acne/acneiform conditions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is three-membered : Chalcogen bonded directly to the hetero ring)

Patent 6071956: Treatment of tissues to reduce subsequent response to injury
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heavy metal containing DOAI : Mercury : Ring in alcohol moiety)

Patent 6071957: Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Cyano or isocyano bonded directly to carbon : Benzene ring containing : C=O other than as ketone or aldehyde : The cyano is bonded directly to a benzene ring : Chalcogen or nitrogen bonded directly to the hetero ring)

Patent 6071958: Ophthalmic carrier solution
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Z-C(=O)-O-Y, wherein Z contains a benzene ring : Z or Y radical contains a nitrogen atom : The nitrogen of the Z radical is directly bonded to a benzene ring which is directly bonded to the C(=O) group : Chalcogen or nitrogen bonded directly to the hetero ring)

Patent 6071959: Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Z-C(=O)-O-Y, wherein Z contains a benzene ring : Z or Y radical contains a nitrogen atom : The nitrogen of the Z radical is directly bonded to a benzene ring which is directly bonded to the C(=O) group : Chalcogen or nitrogen bonded directly to the hetero ring)

Patent 6071960: Polyol succinates and their pharmaceutical formulation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Compound contains two or more C(=O)O groups : Nitrogen bonded to carbon in Z moiety)

Patent 6071961: Antimicrobial composition and methods of use therefor
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 6071962: Oxa acids and related compounds for treating skin conditions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Higher fatty acid or salt thereof : Z contains an unbroken chain of at least seven carbon atoms bonded directly to the C(=O) group)

Patent 6071963: Water dispersible compositions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Higher fatty acid or salt thereof : Carbon to carbon unsaturation : Ring is alcohol moiety)

Patent 6071964: Diclofenac/gamma-cyclodextrin inclusion compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Nitrogen other than as nitro or nitroso nonionically bonded : Benzene ring nonionically bonded : Polycarboxylic acid)

Patent 6071965: Phosphinic alkanoic acid derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Polycarboxylic acid or salt thereof : Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.))

Patent 6071966: 1-amino-alkylcyclohexane NMDA receptor antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Acyclic acid or salt thereof)

Patent 6071968: Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : R contains benzene ring : R contains benzene ring)

Patent 6071969: Substituted aminoguanidines and methods of use thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Amidines (i.e., N=C-N) : Guanidines (i.e., N=C(-N)-N) : R is hydrogen or a lower saturated alkyl of less than seven carbons)

Patent 6071970: Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Benzene ring containing : Two aryl rings or aryl ring systems bonded directly to the same acyclic carbon : Biguanides (i.e., N=C(-N)-N(N-)C=N))

Patent 6071971: Desformoterol compositions useful for inducing bronchodilation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Benzene ring containing : Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain : Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.) : Alkanol group only between the amino nitrogen and an ether oxygen which is bonded directly to the aryl ring or aryl ring system (i.e., aryloxy alkanol amines))

Patent 6071972: Disinfecting and sterilizing concentrate containing and aromatic dialdehyde and a neutral pH buffering system
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Aldehyde DOAI : With preservative or stabilizer : With nitrogen containing compound)

Patent 6071973: Repellent for ants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : C-O-group (e.g., alcohol, alcoholate, etc.) DOAI : Acyclic)

Patent 6071974: Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : C-O-group (e.g., alcohol, alcoholate, etc.) DOAI : Benzene ring containing : C of C-O- group is nuclear C of a benzene ring (e.g., phenol, phenolate, etc.) : Plural benzene rings)

Patent 6071975: Method of preparing silicone oil-in-water microemulsions
(COLLOID SYSTEMS AND WETTING AGENTS; SUBCOMBINATIONS THEREOF; PROCESSES OF : CONTINUOUS LIQUID OR SUPERCRITICAL PHASE: COLLOID SYSTEMS; COMPOSITIONS AN AGENT FOR MAKING OR STABILIZING COLLOID SYSTEMS; PROCESSES OF MAKING OR STABILIZING COLLOID SYSTEMS; PROCESSES OF PREPARING THE COMPOSITIONS (E.G., MICELLE; THICKENING AGENT; PROTECTIVE COLLOID AGENT; COMPOSITION CONTAINING AN EMULSIFYING AGENT WITH NO DISPERSANT DISCLOSED; ORGANIC LIQUID EMULSIFIED IN ANHYDROUS HF) : Aqueous continuous liquid phase and discontinuous phase primarily organic liquid (e.g., organosilicon* oil- or mineral-oil*-in-water, o/w emulsion) : The agent contains organic compound containing sulfoxy* (e.g., sodium lauryl sulfate) : The compound contains repeating -(OCnH2n)- (i.e., repeating unsubstituted oxyalkylene))

Patent 6071976: Water absorbing agent, manufacturing method thereof, and manufacturing machine thereof
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Treating polycarbonamide)

Patent 6071977: Hydrosilation in high boiling natural vegetable oils
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product formation prior to or during solid polymer formation in the presence of a stated ingredient other than water : Ingredient contains a silicon atom as part an organic compound : Organic silicon compound contains an ether group : Organic phosphorus compound contains a phosphorus atom bonded to an atom other than oxygen)

Patent 6071978: Method of producing hydrocarbon-expanded rigid polyurethane foams
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product formation prior to or during solid polymer formation in the presence of a stated ingredient other than water : Ingredient contains only carbon and hydrogen atoms, only C and halogen atoms, or only C, H, and halogen atoms : Nitrogen compound contains a nitrogen atom bonded to three carbon atoms and wherein none of the carbon atoms are double-bonded to oxygen)

Patent 6071979: Photoreactor composition method of generating a reactive species and applications therefor
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : COMPOSITIONS TO BE POLYMERIZED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR COMPOSITIONS TO BE MODIFIED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR PROCESSES OF PREPARING OR TREATING A SOLID POLYMER UTILIZING WAVE ENERGY : Compositions to be polymerized or modified by wave energy wherein said composition contains at least one specified rate-affecting material; or processes of preparing or treating a solid polymer utilizing wave energy in the presence of at least one specified rate-affecting material; e.g., nitrogen containing photosensitizer, oxygen containing photoinitiator, etc. wave energy in order to prepare a cellular product : Specified rate-affecting material contains a ketone group -c-(CO)n-c-, the (CO)n not being part of a ring : Containing ethylenic unsaturation : Specified rate-affecting material contains only carbon, hydrogen, or halogen and at least one atom of carbon is bonded to hydrogen or a halogen atom)

Patent 6071980: Atom transfer radical polymerization
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : COMPOSITIONS TO BE POLYMERIZED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR COMPOSITIONS TO BE MODIFIED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR PROCESSES OF PREPARING OR TREATING A SOLID POLYMER UTILIZING WAVE ENERGY : Compositions to be polymerized or modified by wave energy wherein said composition contains at least one specified rate-affecting material; or processes of preparing or treating a solid polymer utilizing wave energy in the presence of at least one specified rate-affecting material; e.g., nitrogen containing photosensitizer, oxygen containing photoinitiator, etc. wave energy in order to prepare a cellular product : Specified rate-affecting material contains metal atom : Hydroperoxide)

Patent 6071981: Anti-immunoresponsive polymeric material and its use in biological applications
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : PROCESSES OF PREPARING A DESIRED OR INTENTIONAL COMPOSITION OF AT LEAST ONE NONREACTANT MATERIAL AND AT LEAST ONE SOLID POLYMER OR SPECIFIED INTERMEDIATE CONDENSATION PRODUCT, OR PRODUCT THEREOF : Nonmedicated composition specifically intended for contact with living animal tissue or process of preparing; other than apparel : Food release coating)

 

Back to EveryPatent.com